SCHEMBL21351983

SCHEMBL21351983

[c]1nc2c(-c3ncccn3)cccc2s1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6487723 0.86 LIMK1 (0.30)
SCHEMBL10411212 0.85
SCHEMBL9837227 0.81 KDM4E (0.41)
SCHEMBL8942364 0.79 ADORA2A (0.32)
SCHEMBL4337978 0.78 LIMK1 (0.39)
SCHEMBL16150637 0.77 NOTUM (0.38)
SCHEMBL8101802 0.76 ADRA1A (0.34)
SCHEMBL6222047 0.76 HPGDS (0.36)
SCHEMBL7449763 0.74 CLK4 (0.33)
SCHEMBL11200488 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745389-B2 HDAC6 selective inhibitors, preparation method therefor, and application thereof CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD. (CN) 2020-08-18 US disclosed
EP-3569592-A1 HDAC6 SELECTIVE INHIBITORS, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF CSTONE PHARMACEUTICAL (SUZHOU) CO., LTD. (CN) 2019-11-20 EP disclosed
US-20190284192-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD. (CN) 2019-09-19 US disclosed
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed